MIRACLE-LIKE CURES AT LOW COST; PRE-PANDEMIC NON-PROFESSIONAL; SUBSCRIPTION NEAR-HIT MEDICINES AND CONTINUOUS HEALTH INSURANCE INDUSTRY PROFITABILITY SUPPORTED BY LACKADAISICAL PREVENTION; SARS-COV-2 AFFECTED SUBSIDIZED BIO-TECH AND BIG PHARMA; MID- AND POST-PANDEMIC NON-PROFESSIONAL